» Articles » PMID: 26494484

Possible Involvement of Serum and Synovial Fluid Resistin in Knee Osteoarthritis: Cartilage Damage, Clinical, and Radiological Links

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2015 Oct 24
PMID 26494484
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Resistin is an adipocytokine associated with inflammation and insulin resistance. Recent studies have shown that resistin plays an important role in the pathogenesis and progression in osteoarthritis (OA) patients. The current study was aimed at investigating the relationship between resistin in serum and synovial fluid (SF) and disease severity in patients with knee osteoarthritis.

Method: Seventy-four patients diagnosed with knee OA and 79 healthy controls receiving regular body check in our hospital were recruited in the study. The Noyes score method was used to assess articular cartilage damage arthroscopically. The symptomatic severity was evaluated according to the Western Ontario McMaster University Osteoarthritis (WOMAC) scores. The radiographic disease severity of OA was assessed by the Kellgren-Lawrence (K-L) grading system. The resistin levels in serum and SF were determined by enzyme-linked immunosorbent assay. Cartilage degradation marker CTX-II in SF was also examined.

Results: SF but not serum resistin levels are positively associated with Noyes scores, K-L grading scores WOMAC pain scores, physical functional scores and WOMAC total scores. In addition, SF resistin correlated positively with CTX-II.

Conclusion: Resistin in SF might serve as a potential biomarker for reflecting the disease severity and cartilage degenerative extent of knee OA.

Citing Articles

Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis.

Zhang Q, Zhao Y, Li L, Fan Q, Huang B, Du H J Inflamm Res. 2025; 18:1207-1233.

PMID: 39886385 PMC: 11780177. DOI: 10.2147/JIR.S499835.


The Role of Adipokines between Genders in the Pathogenesis of Osteoarthritis.

Economou A, Mallia I, Fioravanti A, Gentileschi S, Nacci F, Bellando Randone S Int J Mol Sci. 2024; 25(19).

PMID: 39409194 PMC: 11476677. DOI: 10.3390/ijms251910865.


The role of obesity and adipose tissue dysfunction in osteoarthritis pain.

Binvignat M, Sellam J, Berenbaum F, Felson D Nat Rev Rheumatol. 2024; 20(9):565-584.

PMID: 39112603 DOI: 10.1038/s41584-024-01143-3.


Adipokine Signaling Pathways in Osteoarthritis.

Zhang C, Lin Y, Yan C, Zhang W Front Bioeng Biotechnol. 2022; 10:865370.

PMID: 35519618 PMC: 9062110. DOI: 10.3389/fbioe.2022.865370.


The Association of Blood Biomarkers and Body Mass Index in Knee Osteoarthritis: A Cross-Sectional Study.

Schadler P, Lohberger B, Thauerer B, Faschingbauer M, Kullich W, Stradner M Cartilage. 2022; 13(1):19476035211069251.

PMID: 35094602 PMC: 9137302. DOI: 10.1177/19476035211069251.


References
1.
Koskinen A, Vuolteenaho K, Moilanen T, Moilanen E . Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3. Scand J Rheumatol. 2014; 43(3):249-53. DOI: 10.3109/03009742.2013.853096. View

2.
Thommesen L, Stunes A, Monjo M, Grosvik K, Tamburstuen M, Kjobli E . Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem. 2006; 99(3):824-34. DOI: 10.1002/jcb.20915. View

3.
Choe J, Bae J, Jung H, Park S, Lee H, Kim S . Serum resistin level is associated with radiographic changes in hand osteoarthritis: cross-sectional study. Joint Bone Spine. 2011; 79(2):160-5. DOI: 10.1016/j.jbspin.2011.04.009. View

4.
Goldring M . The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000; 43(9):1916-26. DOI: 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I. View

5.
Kraus V, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M . Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage. 2011; 19(5):515-42. PMC: 3568396. DOI: 10.1016/j.joca.2010.08.019. View